Actively hiring
Biotechnology
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Yseop is a French company founded in 2008 and specialised in natural language generation for regulated industries. Its software writes financial and pharmaceutical reports from structured data with full traceability of every sentence. The company works mainly with life sciences groups that must produce regulatory documents at scale.
News
AI Doesn't Save Time. Until It Does.
At DIA 2026, a sentiment surfaced repeatedly across sessions that rarely gets stated plainly: AI isn't saving time the way anyone expected. Not because the technology isn't capable, but because generating a fluent draft is not the same as removing work fr
Read more
Report
Yseop named to Fast Company's 2026 World Changing Ideas list
New York, June 16, 2026 - Yseop has been recognized in Fast Company's 2026 World Changing Ideas Awards for helping life sciences organizations transform regulatory writing through AI, streamlining one of the most critical stages of the drug development pr
Read more
Report
The Build-vs-Buy Debate Is the Wrong One for Regulatory-Grade AI
The fastest path to regulatory-grade AI is rarely the one that starts from scratch - and rarely the one that hands over control. Here is how mature pharma organizations are doing both. Regulatory-grade AI refers to AI systems designed for regulated life s
Read more
Report
Yseop Featured in mind Health: Accelerating Drug Approvals with Regulatory-Grade AI
Originally founded in 2007, Yseop first developed natural language generation solutions for financial services. The company made a strategic shift to life sciences, driven by a clear need: helping pharmaceutical companies automate the creation of regulato
Read more
Report
The Next Standard for AI in Life Sciences: Regulatory-Grade AI
Why neuro-symbolic AI is becoming essential for trusted regulatory workflows By Emmanuel Walckenaer, CEO of Yseop Artificial intelligence has made remarkable progress in recent years. Systems that once struggled to produce coherent text can now summarize
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
